Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.

@article{Sherman2003DoesPA,
  title={Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.},
  author={Stuart S Sherman and Urszula Blaut and James L. Watkins and Jeffrey Barnett and Martin Freeman and Joseph E. Geenen and Michael B Ryan and Harrison Parker and James T. Frakes and Evan L. Fogel and William B. Silverman and Kulwinder S Dua and Giuseppe Aliperti and P. N. Yakshe and Michael Uzer and Whitney Jones and John M. Goff and Dee Earle and M'hamed H. Temkit and Glen A. Lehman},
  journal={Gastrointestinal endoscopy},
  year={2003},
  volume={58 1},
  pages={23-9}
}
BACKGROUND Pancreatitis is the most common major complication of diagnostic and therapeutic ERCP. There have been continuing efforts to identify a pharmacologic agent capable of reducing the frequency and severity of this complication. On the basis of several case reports, experimental data, and knowledge of their mechanism of action, corticosteroids might be effective in this regard. The aim of this randomized, double-blind, controlled trial was to determine whether prophylactic, orally… CONTINUE READING
20 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Similar Papers

Loading similar papers…